Verdure Sciences   Report issue

For profit Phase 2
Founded: Noblesville IN United States (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
2009
NCT01001637
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Verdure Sciences

Active Ingredients

Drugs in Phase 2 Trials (1)

curcumin (2 trials)

Drugs in Other Trials (2)

pomegranate (1 trial)

red maple leaf extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3